Understanding Female Infertility — Free Webinar · 22 Oct · 6:30 PM (AEDT)
  • Home
  • About Us
  • Services
  • Specialists
  • Resources
  • Locations
  • Costs
  • Contact
  • About CHA

    Our Research

    From Firsts to Futures:

    A Legacy of Firsts Shaping Fertility Care

    Since its founding in 1964, CHA has combined world-class healthcare with cutting-edge research to transform reproductive medicine. Over six decades, our institutions have pioneered advances that became global standards:

    Our Key Milestones

    Fertility. CHA has pioneered global firsts in IVF and stem cell research —now international standards. With over four decades of innovation, world-class facilities, and an integrated ecosystem, we rank among the global top three in scale and outcomes.

    Stem Cell. CHA has pioneered global firsts in IVF and stem cell research —now international standards. With over four decades of innovation, world-class facilities, and an integrated ecosystem, we rank among the global top three in scale and outcomes.

    Stem Cell. CHA has pioneered global firsts in IVF and stem cell research —now international standards. With over four decades of innovation, world-class facilities, and an integrated ecosystem, we rank among the global top three in scale and outcomes.

    Stem Cell. CHA has pioneered global firsts in IVF and stem cell research —now international standards. With over four decades of innovation, world-class facilities, and an integrated ecosystem, we rank among the global top three in scale and outcomes.

    These milestones are not isolated achievements—they are part of a continuous tradition of discovery that defines the CHA brand.

    Why Our Research Matters Globally

    Infertility affects more than 1 in 6 people worldwide. CHA’s research directly addresses this challenge by:
    Expanding Possibilities
    Developing solutions for patients once told they had no chance of conceiving.
    Improving Outcomes
    Elevating IVF success rates into the top 1% globally, across all age groups.
    Preserving Futures
    Pioneering fertility preservation for cancer patients, and families delaying parenthood.
    Our Promise

    Commitment to Ongoing Innovation

    Today, CHA’s research agenda continues to lead globally through:

    AI-Driven Embryo Selection

    Harnessing artificial intelligence to improve embryo grading accuracy and outcomes.

    Advanced Reproductive Genetics

    Expanding genetic testing to identify chromosomal abnormalities, hereditary conditions, and optimize embryo transfer.

    Stem Cell & Regenerative Medicine

    Leveraging CHA Biotech’s breakthroughs to explore future fertility and reproductive health therapies.

    Global Research Collaborations

    Partnerships with universities, medical centers, and biotech leaders worldwide ensure CHA remains at the cutting edge.

    Education & Knowledge Sharing

    CHA University’s international programs and conferences train fertility specialists and researchers across Asia–Pacific and beyond.

    The CHA Difference

    Creating Tomorrow’s
Fertility Care

    Unlike many fertility networks, CHA does more than deliver treatment, it creates the science that defines the future of fertility care.
    Every discovery in our labs and institutes is designed with one purpose: to help more patients achieve the dream of family.

    Patients and partners benefit from:
    A brand synonymous with trust, innovation, and results.

    We show our committment by reducing the environmental impact of labs by [XX], [XX], [XX]

    A network that integrates hospitals, research labs, and biotech under one vision.

    A network that integrates hospitals, research labs, and biotech under one vision.

    Outcomes that consistently set global standards.

    By building global accessibility for fertility treatments, we strive to create not only healthier families, but a healthier, more equitable world.

    Looking Ahead

    Redefining Fertility,
Delivering Breakthroughs.

    As fertility challenges rise worldwide, CHA’s mission remains clear:
    to redefine the boundaries of reproductive medicine and deliver those breakthroughs directly to patients. For more than six decades, CHA’s research has turned possibility into reality. For the future, it promises to bring even greater hope with ongoing R&D into menopause, POI and complex issues to further expand 
every prospective parent’s biological

    Want to know more?

    Journal of Sustainable Engineering, 2025 This paper explores efficient integration methods for solar and wind energy systems in densely populated areas. It presents a novel algorithm to maximize energy yield while minimizing infrastructure footprint.

    Reach out to us

    See Our Research

    Optimizing Renewable Energy Systems for Urban Environments – Topic 3

    Journal of Sustainable Engineering, 2025 This pape…

    More

    AI for Early Disease Detection

    The early detection of rare and chronic diseases s…

    More

    Optimizing Renewable Energy Systems for Urban Environments

    Journal of Sustainable Engineering, 2025 This pape…

    More

    Optimizing Renewable Energy Systems for Urban Environments

    Journal of Sustainable Engineering, 2025 This pape…

    More

    Optimizing Renewable Energy Systems for Urban Environments

    Journal of Sustainable Engineering, 2025 This pape…

    More

    Optimizing Renewable Energy Systems for Urban Environments – Topic 3

    Journal of Sustainable Engineering, 2025 This pape…

    More

    AI for Early Disease Detection

    The early detection of rare and chronic diseases s…

    More

    Optimizing Renewable Energy Systems for Urban Environments

    Journal of Sustainable Engineering, 2025 This pape…

    More
    Request your free info pack today
    By completing this form, you are expressing interest to have a copy of our free fertility information pack.

      I have read and agree to the terms of City Fertility's Privacy Collection Statement and Privacy Policy